A landscape of metabolic variation across tumor types

Hallmarks of Cancer: The Next Generation

Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590 · see citing works

Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation

Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197 · see citing works

Inferring tumour purity and stromal and immune cell admixture from expression data

Yoshihara, K., Shahmoradgoli, M., Martínez, E., Vegesna, R., Kim, H., Torres-Garcia, W., Treviño, V., Shen, H., Laird, P. W., Levine, D. A., et al. (2013) · Nature Communications · doi:10.1038/ncomms3612 · Cited by 9,778 · see citing works

Microenvironmental regulation of tumor progression and metastasis

Quail, D. F., & Joyce, J. A. (2013) · Nature Medicine · doi:10.1038/nm.3394 · Cited by 7,994 · see citing works

KEGG as a reference resource for gene and protein annotation

Kanehisa, M., Sato, Y., Kawashima, M., Furumichi, M., & Tanabe, M. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1070 · Cited by 7,387 · see citing works

The emerging hallmarks of cancer metabolism

Pavlova, N. N., & Thompson, C. B. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.006 · Cited by 5,926 · see citing works

PubChem Substance and Compound databases

Kim, S., Thiessen, P. A., Bolton, E. E., Chen, J., Fu, G., Gindulyte, A., Han, L., He, J., He, S., Shoemaker, B. A., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv951 · Cited by 5,436 · see citing works

Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression

Chang, C.-H., Qiu, J., O’Sullivan, D., Buck, M. D., Noguchi, T., Curtis, J. D., Chen, Q., Gindin, M., Gubin, M. M., van der Windt, G. J. W., et al. (2015) · Cell · doi:10.1016/j.cell.2015.08.016 · Cited by 3,331 · see citing works

HMDB: the Human Metabolome Database

Wishart, D. S., Tzur, D., Knox, C., Eisner, R., Guo, A. C., Young, N., Cheng, D., Jewell, K., Arndt, D., Sawhney, S., et al. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkl923 · Cited by 3,219 · see citing works

Discovery and saturation analysis of cancer genes across 21 tumour types

Lawrence, M. S., Stojanov, P., Mermel, C. H., Robinson, J. T., Garraway, L. A., Golub, T. R., Meyerson, M., Gabriel, S. B., Lander, E. S., & Getz, G. (2014) · Nature · doi:10.1038/nature12912 · Cited by 3,096 · see citing works

Fundamentals of Cancer Metabolism

DeBerardinis, R. J., & Chandel, N. S. (2016) · Science Advances · doi:10.1126/sciadv.1600200 · Cited by 3,013 · see citing works

Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent Dioxygenases

Xu, W., Yang, H., Liu, Y., Yang, Y., Wang, P., Kim, S.-H., Ito, S., Yang, C., Wang, P., Xiao, M.-T., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2010.12.014 · Cited by 2,875 · see citing works

Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression

Sreekumar, A., Poisson, L., Rajendiran, T. M., Khan, A. P., Cao, Q., Yu, J., Laxman, B., Mehra, R., Lonigro, R. J., Li, Y., et al. (2009) · Nature · doi:10.1038/nature07762 · Cited by 2,238 · see citing works

DrugBank 4.0: shedding new light on drug metabolism

Law, V., Knox, C., Djoumbou-Feunang, Y., Jewison, T., Guo, A. C., Liu, Y., Maciejewski, A., Arndt, D., Wilson, M., Neveu, V., et al. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt1068 · Cited by 1,995 · see citing works

IDH mutation impairs histone demethylation and results in a block to cell differentiation

Lu, C., Ward, P. S., Kapoor, G. S., Rohle, D., Turcan, S., Abdel-Wahab, O., Edwards, C. R., Khanin, R., Figueroa, M. E., Melnick, A., et al. (2012) · Nature · doi:10.1038/nature10860 · Cited by 1,985 · see citing works

Functional genomics reveal that the serine synthesis pathway is essential in breast cancer

Possemato, R., Marks, K. M., Shaul, Y. D., Pacold, M. E., Kim, D., Birsoy, K., Sethumadhavan, S., Woo, H.-K., Jang, H. G., Jha, A. K., et al. (2011) · Nature · doi:10.1038/nature10350 · Cited by 1,683 · see citing works

Emerging landscape of oncogenic signatures across human cancers

Ciriello, G., Miller, M. L., Aksoy, B. A., Şenbabaoğlu, Y., Schultz, N. D., & Sander, C. (2013) · Nature Genetics · doi:10.1038/ng.2762 · Cited by 1,382 · see citing works

Reductive carboxylation supports growth in tumour cells with defective mitochondria

Mullen, A. R., Wheaton, W. W., Jin, E. S., Chen, P.-H., Sullivan, L. B., Cheng, T., Yang, Y., Linehan, W. M., Chandel, N. S., & DeBerardinis, R. J. (2012) · Nature · doi:10.1038/nature10642 · Cited by 1,328 · see citing works

Polyamines and cancer: old molecules, new understanding

Gerner, E. W., & Meyskens, F. L. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1454 · Cited by 1,163 · see citing works

Metabolic heterogeneity in human lung tumors

Hensley, C. T., Faubert, B., Yuan, Q., Lev-Cohain, N., Jin, E., Kim, J., Jiang, L., Ko, B., Skelton, R., Loudat, L., et al. (2016) · Cell · doi:10.1016/j.cell.2015.12.034 · Cited by 1,138 · see citing works

Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion

Sousa, C. M., Biancur, D. E., Wang, X., Halbrook, C. J., Sherman, M. H., Zhang, L., Kremer, D., Hwang, R. F., Witkiewicz, A. K., Ying, H., et al. (2016) · Nature · doi:10.1038/nature19084 · Cited by 1,122 · see citing works

Pathway Commons, a web resource for biological pathway data

Cerami, E. G., Gross, B. E., Demir, E., Rodchenkov, I., Babur, O., Anwar, N., Schultz, N., Bader, G. D., & Sander, C. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1039 · Cited by 1,101 · see citing works

Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein

Kamphorst, J. J., Nofal, M., Commisso, C., Hackett, S. R., Lu, W., Grabocka, E., Vander Heiden, M. G., Miller, G., Drebin, J. A., Bar-Sagi, D., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2211 · Cited by 893 · see citing works

An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma

Hakimi, A. A., Reznik, E., Lee, C., Creighton, C. J., Brannon, A. R., Luna, A., Aksoy, B. A., Liu, E. M., Shen, R., Lee, W., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2015.12.004 · Cited by 791 · see citing works

Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases

Casero, R. A., & Marton, L. J. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2243 · Cited by 752 · see citing works

Tryptophan Catabolism in Cancer: Beyond IDO and Tryptophan Depletion

Platten, M., Wick, W., & den Eynde, B. J. V. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0569 · Cited by 708 · see citing works

A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations

Zhang, Y., Kwok-Shing Ng, P., Kucherlapati, M., Chen, F., Liu, Y., Tsang, Y. H., de Velasco, G., Jeong, K. J., Akbani, R., Hadjipanayis, A., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.04.013 · Cited by 626 · see citing works

Metabolic enzyme expression highlights a key role for MTHFD2 and the mitochondrial folate pathway in cancer

Nilsson, R., Jain, M., Madhusudhan, N., Sheppard, N. G., Strittmatter, L., Kampf, C., Huang, J., Asplund, A., & Mootha, V. K. (2014) · Nature Communications · doi:10.1038/ncomms4128 · Cited by 607 · see citing works

Kynurenine Pathway Metabolites in Humans: Disease and Healthy States

Chen, Y.-Q., & Guillemin, G. (2009) · International Journal of Tryptophan Research · doi:10.4137/ijtr.s2097 · Cited by 589 · see citing works

Tissue of origin dictates branched-chain amino acid metabolism in mutant <i>Kras</i> -driven cancers

Mayers, J. R., Torrence, M. E., Danai, L. V., Papagiannakopoulos, T., Davidson, S. M., Bauer, M. R., Lau, A. N., Ji, B. W., Dixit, P. D., Hosios, A. M., et al. (2016) · Science · doi:10.1126/science.aaf5171 · Cited by 582 · see citing works

Fructose-1,6-bisphosphatase opposes renal carcinoma progression

Li, B., Qiu, B., Lee, D. S. M., Walton, Z. E., Ochocki, J. D., Mathew, L. K., Mancuso, A., Gade, T. P. F., Keith, B., Nissim, I., et al. (2014) · Nature · doi:10.1038/nature13557 · Cited by 535 · see citing works

Mitochondrial DNA copy number variation across human cancers

Reznik, E., Miller, M. L., Şenbabaoğlu, Y., Riaz, N., Sarungbam, J., Tickoo, S. K., Al‐Ahmadie, H. A., Lee, W., Seshan, V., Hakimi, A. A., et al. (2016) · eLife · doi:10.7554/elife.10769 · Cited by 515 · see citing works

MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis

Terunuma, A., Putluri, N., Mishra, P., Mathé, E. A., Dorsey, T. H., Yi, M., Wallace, T. A., Issaq, H. J., Zhou, M., Killian, J. K., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71180 · Cited by 428 · see citing works

A diverse array of cancer-associated mTOR mutations are hyperactivating and can predict rapamycin sensitivity

Grabiner, B., Nardi, V., Birsoy, K., Possemato, R., Shen, K., Sinha, S., Jordan, A. A., Beck, A. H., & Sabatini, D. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0929 · Cited by 418 · see citing works

The microenvironment in breast cancer progression: biology and implications for treatment

Place, A. E., Huh, S. J., & Polyák, K. (2011) · Breast Cancer Research · doi:10.1186/bcr2912 · Cited by 415 · see citing works

Heterogeneity of tumor-induced gene expression changes in the human metabolic network

Hu, J., Locasale, J. W., Bielas, J. H., O'Sullivan, J., Sheahan, K., Cantley, L. C., Heiden, M. G. V., & Vitkup, D. (2013) · Nature Biotechnology · doi:10.1038/nbt.2530 · Cited by 407 · see citing works

Altered metabolite levels in cancer: implications for tumour biology and cancer therapy

Sullivan, L. B., Gui, D. Y., & Heiden, M. G. V. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.85 · Cited by 406 · see citing works

Integration of Metabolomics and Transcriptomics Revealed a Fatty Acid Network Exerting Growth Inhibitory Effects in Human Pancreatic Cancer

Zhang, G., He, P., Tan, H., Budhu, A., Gaedcke, J., Ghadimi, Β. M., Ried, T., Yfantis, H. G., Lee, D. H., Maitra, A., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0209 · Cited by 353 · see citing works

Depletion of cellular polyamines, spermidine and spermine, causes a total arrest in translation and growth in mammalian cells

Mandal, S., Mandal, A., Johansson, H. E., Orjalo, A. V., & Park, M. H. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219002110 · Cited by 285 · see citing works

<scp>l</scp> -2-Hydroxyglutarate: An Epigenetic Modifier and Putative Oncometabolite in Renal Cancer

Shim, E.-H., Livi, C. B., Rakheja, D., Tan, J., Benson, D., Parekh, V., Kho, E.-Y., Ghosh, A. P., Kirkman, R., Velu, S., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0696 · Cited by 280 · see citing works

L-2-Hydroxyglutarate production arises from noncanonical enzyme function at acidic pH

Intlekofer, A. M., Wang, B., Liu, H., Shah, H., Carmona-Fontaine, C., Rustenburg, A. S., Salah, S., Gunner, M. R., Chodera, J. D., Cross, J. R., et al. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2307 · Cited by 268 · see citing works

Kynurenine pathway metabolomics predicts and provides mechanistic insight into multiple sclerosis progression

Lim, C. K., Bilgin, A. A., Lovejoy, D., Tan, V., Bustamante, S., Taylor, B., Bessède, A., Brew, B., & Guillemin, G. (2017) · Scientific Reports · doi:10.1038/srep41473 · Cited by 224 · see citing works

A systematic comparison of methods for combining p-values from independent tests

Loughin, T. M. (2004) · Computational Statistics & Data Analysis · doi:10.1016/j.csda.2003.11.020 · Cited by 220 · see citing works

Metabolomic Profiling Reveals Potential Markers and Bioprocesses Altered in Bladder Cancer Progression

Putluri, N., Shojaie, A., Vasu, V. T., Vareed, S. K., Nalluri, S., Putluri, V., Thangjam, G. S., Panzitt, K., Tallman, C. T., Butler, C., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1154 · Cited by 203 · see citing works

A joint analysis of metabolomics and genetics of breast cancer

Tang, X., Lin, C., Spasojević, I., Iversen, E. S., Chi, J., & Marks, J. R. (2014) · Breast Cancer Research · doi:10.1186/s13058-014-0415-9 · Cited by 197 · see citing works

Spermine and Citrate as Metabolic Biomarkers for Assessing Prostate Cancer Aggressiveness

Giskeødegård, G. F., Bertilsson, H., Selnæs, K. M., Wright, A. J., Bathen, T. F., Viset, T., Halgunset, J., Angelsen, A., Gribbestad, I. S., & Tessem, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062375 · Cited by 182 · see citing works

Molecular Analysis for Therapy Choice: NCI MATCH

Conley, B. A., & Doroshow, J. H. (2014) · Seminars in Oncology · doi:10.1053/j.seminoncol.2014.05.002 · Cited by 179 · see citing works

Mitochondrial aconitase and citrate metabolism in malignant and nonmalignant human prostate tissues

Singh, K. K., Desouki, M. M., FRANKLIN, R. B., & Costello, L. C. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-14 · Cited by 171 · see citing works

Identification of Metabolites in the Normal Ovary and Their Transformation in Primary and Metastatic Ovarian Cancer

Fong, M., McDunn, J. E., & Kakar, S. S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019963 · Cited by 170 · see citing works

The Metabolomic Signature of Malignant Glioma Reflects Accelerated Anabolic Metabolism

Chinnaiyan, P., Kensicki, E., Bloom, G. C., Prabhu, A. H., Sarcar, B., Kahali, S., Eschrich, S. A., Qu, X., Forsyth, P. A., & Gillies, R. J. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1572-t · Cited by 168 · see citing works

Aryl Hydrocarbon Receptor and Kynurenine: Recent Advances in Autoimmune Disease Research

Nguyen, N. T., Nakahama, T., Le, D. H., Son, L. V., Hà, C. H., & Kishimoto, T. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00551 · Cited by 165 · see citing works

Pseudo-transition Analysis Identifies the Key Regulators of Dynamic Metabolic Adaptations from Steady-State Data

Gerosa, L., van Rijsewijk, B. R. B. H., Christodoulou, D., Kochanowski, K., Schmidt, T., Noor, Ε., & Sauer, U. (2015) · Cell Systems · doi:10.1016/j.cels.2015.09.008 · Cited by 157 · see citing works

Induction of sarcomas by mutant IDH2Preprint

Lü, C., Venneti, S., Akalin, A., Fang, F., Ward, P. S., Dematteo, R. G., Intlekofer, A. M., Chen, C., Ye, J., Hameed, M., et al. (2013) · Genes & Development · doi:10.1101/gad.226753.113 · Cited by 157 · see citing works

The Chemical Translation Service—a web-based tool to improve standardization of metabolomic reports

Wohlgemuth, G., Haldiya, P. K., Willighagen, E., Kind, T., & Fiehn, O. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq476 · Cited by 146 · see citing works

Understanding the role of the kynurenine pathway in human breast cancer immunobiology

Heng, B., Lim, C. K., Lovejoy, D. B., Bessede, A., Gluch, L., & Guillemin, G. J. (2015) · Oncotarget · doi:10.18632/oncotarget.6467 · Cited by 138 · see citing works

Mitochondrial respiratory gene expression is suppressed in many cancers

Reznik, E., Wang, Q., La, K., Schultz, N. D., & Sander, C. (2017) · eLife · doi:10.7554/elife.21592 · Cited by 136 · see citing works

AKT1 and MYC Induce Distinctive Metabolic Fingerprints in Human Prostate Cancer

Priolo, C., Pyne, S., Rose, J. A., Regan, E. R., Zadra, G., Photopoulos, C., Cacciatore, S., Schultz, D., Scaglia, N., McDunn, J. E., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1490 · Cited by 135 · see citing works

Chromosome 3p loss of heterozygosity is associated with a unique metabolic network in clear cell renal carcinoma

Gatto, F., Nookaew, I., & Nielsen, J. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1319196111 · Cited by 132 · see citing works

Pyrimidine homeostasis is accomplished by directed overflow metabolism

Reaves, M. L., Young, B. D., Hosios, A. M., Xu, Y.-F., & Rabinowitz, J. D. (2013) · Nature · doi:10.1038/nature12445 · Cited by 128 · see citing works

Immunosuppression Via Tryptophan Catabolism: The Role of Kynurenine Pathway Enzymes

Belladonna, M. L., Puccetti, P., Orabona, C., Fallarino, F., Vacca, C., Volpi, C., Gizzi, S., Pallotta, M. T., Fioretti, M. C., & Grohmann, U. (2007) · Transplantation · doi:10.1097/01.tp.0000269199.16209.22 · Cited by 115 · see citing works

Meta‐analysis of clinical metabolic profiling studies in cancer: challenges and opportunities

Goveia, J., Pircher, A., Conradi, L., Kalucka, J. M., Lagani, V., Dewerchin, M. A., Eelen, G., DeBerardinis, R. J., Wilson, I. D., & Carmeliet, P. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606798 · Cited by 106 · see citing works

Genomic alterations underlie a pan-cancer metabolic shift associated with tumour hypoxia

Haider, S. A., McIntyre, A., van Stiphout, R. G. P. M., Winchester, L. M., Wigfield, S., Harris, A. L., & Buffa, F. M. (2016) · Genome biology · doi:10.1186/s13059-016-0999-8 · Cited by 90 · see citing works

Role of glutathione in cancer pathophysiology and therapeutic interventions.

Singh, S., Khan, A. R., & GUPTA, A. K. (2012) · PubMed · Cited by 88 · see citing works

Metabolic Profiling of IDH Mutation and Malignant Progression in Infiltrating Glioma

Jalbert, L. E., Elkhaled, A., Phillips, J. J., Neill, E., Williams, A. A., Crane, J. C., Olson, M. P., Molinaro, A. M., Berger, M. S., Kurhanewicz, J. V., et al. (2017) · Scientific Reports · doi:10.1038/srep44792 · Cited by 79 · see citing works

Flux Imbalance Analysis and the Sensitivity of Cellular Growth to Changes in Metabolite Pools

Reznik, E., Mehta, P., & Segrè, D. (2013) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003195 · Cited by 78 · see citing works

Circulating biomarkers of tryptophan and the kynurenine pathway and lung cancer risk.

Chuang, S., Fanidi, A., Ueland, P., Relton, C., Midttun, Ø., Vollset, S., Gunter, M., Seckl, M., Travis, R., Wareham, N., et al. (2014) · Cancer Epidemiology, Biomarkers and Prevention · doi:10.1158/1055-9965.epi-13-0770 · Cited by 75 · see citing works

After the feature presentation: technologies bridging untargeted metabolomics and biology

Cho, K., Mahieu, N. G., Johnson, S. L., & Patti, G. J. (2014) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2014.04.006 · Cited by 47 · see citing works

Extensive Decoupling of Metabolic Genes in Cancer

Reznik, E., & Sander, C. (2015) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004176 · Cited by 38 · see citing works

Multimodal Assessment of In Vivo Metabolism with Hyperpolarized [1-13C]MR Spectroscopy and 18F-FDG PET Imaging in Hepatocellular Carcinoma Tumor–Bearing Rats

Menzel, M. I., Farrell, E. V., Janich, M., Khegai, O., Wiesinger, F., Nekolla, S. G., Otto, A. M., Haase, A., Schulte, R. F., & Schwaiger, M. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.110825 · Cited by 34 · see citing works

PaxtoolsR: pathway analysis in R using Pathway Commons

Luna, A., Babur, Ö., Aksoy, B. A., Demir, E., & Sander, C. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btv733 · Cited by 28 · see citing works

Enhancing immunotherapy in cancer by targeting emerging immunomodulatory pathways

Kraehenbuehl, L., Weng, C.-H., Eghbali, S., Wolchok, J., & Merghoub, T. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00552-7 · Cited by 731 · see citing works

CD8+ T cell metabolism in infection and cancer

Reina-Campos, M., Scharping, N. E., & Goldrath, A. W. (2021) · Nature reviews. Immunology · doi:10.1038/s41577-021-00537-8 · Cited by 574 · see citing works

Metabolic landscape of the tumor microenvironment at single cell resolution

Xiao, Z., Dai, Z., & Locasale, J. W. (2019) · Nature Communications · doi:10.1038/s41467-019-11738-0 · Cited by 524 · see citing works

Metabolic-Pathway-Based Subtyping of Triple-Negative Breast Cancer Reveals Potential Therapeutic Targets

Gong, Y., Ji, P., Yang, Y., Xie, S., Yu, T., Xiao, Y., Jin, M., Ma, D., Guo, L., Pei, Y., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.10.012 · Cited by 472 · see citing works

The Evasion Mechanisms of Cancer Immunity and Drug Intervention in the Tumor Microenvironment

Kim, S. K., & Cho, S. W. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.868695 · Cited by 473 · see citing works

Reimagining IDO Pathway Inhibition in Cancer Immunotherapy via Downstream Focus on the Tryptophan–Kynurenine–Aryl Hydrocarbon Axis

Labadie, B. W., Bao, R., & Luke, J. J. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-2882 · Cited by 413 · see citing works

Comprehensive metabolomics expands precision medicine for triple-negative breast cancer

Xiao, Y., Ma, D., Yang, Y., Yang, F., Ding, J.-H., Gong, Y., Jiang, L., Ge, L., Wu, S., Yu, Q., et al. (2022) · Cell Research · doi:10.1038/s41422-022-00614-0 · Cited by 330 · see citing works

Metabolic interventions in the immune response to cancer

O’Sullivan, D., Sanin, D. E., Pearce, E. J., & Pearce, E. L. (2019) · Nature reviews. Immunology · doi:10.1038/s41577-019-0140-9 · Cited by 314 · see citing works

The Tumor Metabolic Microenvironment: Lessons from Lactate

García‐Cañaveras, J. C., Chen, L., & Rabinowitz, J. D. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3726 · Cited by 247 · see citing works

Serine, glycine and one‑carbon metabolism in cancer (Review)

Pan, S., Fan, M., Liu, Z., Li, X., & Wang, H. (2020) · International Journal of Oncology · doi:10.3892/ijo.2020.5158 · Cited by 227 · see citing works

The Diverse Functions of Non-Essential Amino Acids in Cancer

Choi, B.-H., & Coloff, J. L. (2019) · Cancers · doi:10.3390/cancers11050675 · Cited by 213 · see citing works

The emerging role of lactate in tumor microenvironment and its clinical relevance

Chen, S., Xu, Y., Zhuo, W., & Zhang, L. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216837 · Cited by 200 · see citing works

Targeting pyrimidine synthesis accentuates molecular therapy response in glioblastoma stem cells

Wang, X., Yang, K., Wu, Q., Kim, L. J. Y., Morton, A. R., Gimple, R. C., Prager, B. C., Shi, Y., Zhou, W., Bhargava, S., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aau4972 · Cited by 195 · see citing works

Glioma Stem Cell–Specific Superenhancer Promotes Polyunsaturated Fatty-Acid Synthesis to Support EGFR Signaling

Gimple, R. C., Kidwell, R. L., Kim, L. J. Y., Sun, T., Gromovsky, A. D., Wu, Q., Wolf, M. E., Lv, D., Bhargava, S., Jiang, L., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0061 · Cited by 178 · see citing works

Targeting SLC1A5 and SLC3A2/SLC7A5 as a Potential Strategy to Strengthen Anti-Tumor Immunity in the Tumor Microenvironment

Nachef, M., Ali, A. K., Almutairi, S. M., & Lee, S.-H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.624324 · Cited by 176 · see citing works

Developing dietary interventions as therapy for cancer

Taylor, S. R., Falcone, J. N., Cantley, L. C., & Goncalves, M. D. (2022) · Nature reviews. Cancer · doi:10.1038/s41568-022-00485-y · Cited by 160 · see citing works

Regulatory T cell-mediated immunosuppression orchestrated by cancer: towards an immuno-genomic paradigm for precision medicine

Kumagai, S., Itahashi, K., & Nishikawa, H. (2024) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-024-00870-6 · Cited by 163 · see citing works

Tumour metabolism and its unique properties in prostate adenocarcinoma

Bader, D. A., & McGuire, S. E. (2020) · Nature Reviews Urology · doi:10.1038/s41585-020-0288-x · Cited by 154 · see citing works

The complexity of the serine glycine one-carbon pathway in cancer

Reina‐Campos, M., Díaz-Meco, M. T., & Moscat, J. (2019) · The Journal of Cell Biology · doi:10.1083/jcb.201907022 · Cited by 123 · see citing works

Microenvironmental regulation of cancer cell metabolism: implications for experimental design and translational studies

Muir, A., Danai, L. V., & Heiden, M. G. V. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.035758 · Cited by 121 · see citing works

Disease-specific protein corona sensor arrays may have disease detection capacity

Caracciolo, G., Safavi‐Sohi, R., Malekzadeh, R., Poustchi, H., Vasighi, M., Chiozzi, R. Z., Capriotti, A. L., Laganà, A., Hajipour, M. J., Domenico, M. D., et al. (2019) · Nanoscale Horizons · doi:10.1039/c9nh00097f · Cited by 113 · see citing works

Metabolic Interdependency of Th2 Cell-Mediated Type 2 Immunity and the Tumor Microenvironment

Schreiber, S., Hammers, C. M., Kaasch, A. J., Schraven, B. L., Dudeck, A., & Kahlfuß, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.632581 · Cited by 112 · see citing works

Systematic Dissection of the Metabolic-Apoptotic Interface in AML Reveals Heme Biosynthesis to Be a Regulator of Drug Sensitivity

Lin, K., Xie, A., Rutter, J. C., Ahn, Y.-R., Lloyd-Cowden, J. M., Nichols, A., Soderquist, R. S., Koves, T. R., Muoio, D. M., MacIver, N. J., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.01.011 · Cited by 102 · see citing works

Niclosamide, an antihelmintic drug, enhances efficacy of PD-1/PD-L1 immune checkpoint blockade in non-small cell lung cancer

Luo, F., Luo, M., Rong, Q., Zhang, H., Chen, Z., Wang, F., Zhao, H.-Y., & Fu, L. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0733-7 · Cited by 105 · see citing works

Challenges and Opportunities in Cancer Metabolomics

Kumar, A., & Misra, B. B. (2019) · PROTEOMICS · doi:10.1002/pmic.201900042 · Cited by 100 · see citing works

Genetically programmable cell membrane-camouflaged nanoparticles for targeted combination therapy of colorectal cancer

Yang, Y., Liu, Q., Wang, M., Li, L., Yu, Y. M., Pan, M., Hu, D., Chu, B., Qu, Y., & Qian, Z. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01859-4 · Cited by 97 · see citing works

Defining a metabolic landscape of tumours: genome meets metabolism

Nanda, C. S., Venkateswaran, S. V., Patani, N., & Yuneva, M. O. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0663-7 · Cited by 94 · see citing works

A large-scale analysis of targeted metabolomics data from heterogeneous biological samples provides insights into metabolite dynamics

Lee, H., Kremer, D. M., Sajjakulnukit, P., Zhang, L., & Lyssiotis, C. A. (2019) · Metabolomics · doi:10.1007/s11306-019-1564-8 · Cited by 81 · see citing works

Fighting in a wasteland: deleterious metabolites and antitumor immunity

Watson, M. J., & Delgoffe, G. M. (2022) · Journal of Clinical Investigation · doi:10.1172/jci148549 · Cited by 82 · see citing works

Computational approaches to modelling and optimizing cancer treatment

McDonald, T. O., Cheng, Y.-C., Graser, C. J., Nicol, P. B., Temko, D., & Franziska Michor, A. (2023) · Nature Reviews Bioengineering · doi:10.1038/s44222-023-00089-7 · Cited by 76 · see citing works

Fatty Acid Synthesis in Prostate Cancer: Vulnerability or Epiphenomenon?

Sena, L. A., & Denmeade, S. R. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-1392 · Cited by 73 · see citing works

Inhibition of the polyamine synthesis enzyme ornithine decarboxylase sensitizes triple-negative breast cancer cells to cytotoxic chemotherapy

Geck, R. C., Foley, J. R., Stewart, T. M., Asara, J. M., Casero, R. A., & Toker, A. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.012376 · Cited by 70 · see citing works

An integrated landscape of protein expression in human cancer

Jarnuczak, A. F., Najgebauer, H., Barzine, M., Kundu, D. J., Ghavidel, F. Z., Pérez‐Riverol, Y., Papatheodorou, I., Brāzma, A., & Vizcaíno, J. A. (2021) · Scientific Data · doi:10.1038/s41597-021-00890-2 · Cited by 64 · see citing works

Discrimination of oral squamous cell carcinoma from oral lichen planus by salivary metabolomics

Ishikawa, S., Sugimoto, M., Edamatsu, K., Sugano, A., Kitabatake, K., & Iino, M. (2019) · Oral Diseases · doi:10.1111/odi.13209 · Cited by 63 · see citing works

Targeting Mitochondrial OXPHOS and Their Regulatory Signals in Prostate Cancers

Chen, C., Lin, C., & Kung, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413435 · Cited by 62 · see citing works

Tumor microenvironmental influences on dendritic cell and T cell function: A focus on clinically relevant immunologic and metabolic checkpoints

Hargadon, K. M. (2020) · Clinical and Translational Medicine · doi:10.1002/ctm2.37 · Cited by 61 · see citing works

Overcoming Cancer Resistance: Strategies and Modalities for Effective Treatment

Koirala, M., & DiPaola, M. (2024) · Biomedicines · doi:10.3390/biomedicines12081801 · Cited by 67 · see citing works

Tools and resources for metabolomics research community: A 2017–2018 update

Misra, B. B., & Mohapatra, S. (2018) · Electrophoresis · doi:10.1002/elps.201800428 · Cited by 56 · see citing works

Lactate oxidase/catalase-displaying nanoparticles efficiently consume lactate in the tumor microenvironment to effectively suppress tumor growth

Choi, H., Yeo, M., Kang, Y., Kim, H. J., Park, S. G., Jang, E., Park, S. H., Kim, E., & Kang, S. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01762-6 · Cited by 55 · see citing works

Biosynthetic energy cost for amino acids decreases in cancer evolution

Zhang, H., Wang, Y., Li, J., Chen, H., He, X., Zhang, H., Liang, H., & Lü, J. (2018) · Nature Communications · doi:10.1038/s41467-018-06461-1 · Cited by 49 · see citing works

Targeting metabolic dysfunction of CD8 T cells and natural killer cells in cancer

Viel, S., Vivier, É., Walzer, T., & Marçais, A. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-01098-w · Cited by 51 · see citing works

Data-driven translational prostate cancer research: from biomarker discovery to clinical decision

Lin, Y., Zhao, X. J., Miao, Z., Ling, Z., Wei, X., Pu, J., Hou, J., & Shen, B. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02281-4 · Cited by 48 · see citing works

Scalable reinforcement-learning-based neural architecture search for cancer deep learning research

Balaprakash, P., Égelé, R., Salim, M., Wild, S. M., Vishwanath, V., Xia, F., Brettin, T., & Stevens, R. (2019) · International Conference for High Performance Computing, Networking, Storage and Analysis (SC) · doi:10.1145/3295500.3356202 · Cited by 49 · see citing works

Genetically Encoded ATP Biosensors for Direct Monitoring of Cellular ATP Dynamics

White, D., & Yang, Q. (2022) · Cells · doi:10.3390/cells11121920 · Cited by 47 · see citing works

Abnormal oxidative metabolism in a quiet genomic background underlies clear cell papillary renal cell carcinoma

Xu, J., Reznik, E., Lee, H.-J., Gundem, G., Jonsson, P., Sarungbam, J., Bialik, A., Sanchez-Vega, F., Creighton, C. J., Hoekstra, J., et al. (2019) · eLife · doi:10.7554/elife.38986 · Cited by 43 · see citing works

Diet, nutrient supply, and tumor immune responses

McIntyre, C., Temesgen, A., & Lynch, L. (2023) · Trends in cancer · doi:10.1016/j.trecan.2023.06.003 · Cited by 43 · see citing works

Exploring the relationship between metabolism and immune microenvironment in osteosarcoma based on metabolic pathways

Wu, C., Tan, J., Shen, H., Deng, C., Kleber, C., Osterhoff, G., & Schopow, N. (2024) · Journal of Biomedical Science · doi:10.1186/s12929-024-00999-7 · Cited by 47 · see citing works

A pan-cancer metabolic atlas of the tumor microenvironment

Rohatgi, N., Ghoshdastider, U., Baruah, P., Kulshrestha, T., & Skanderup, A. J. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110800 · Cited by 43 · see citing works

Blocking muscle wasting via deletion of the muscle-specific E3 ligase MuRF1 impedes pancreatic tumor growth

Neyroud, D., Laitano, O., Dasgupta, A., Lopez, C., Schmitt, R. E., Schneider, J. Z., Hammers, D. W., Sweeney, H. L., Walter, G. A., Doles, J. D., et al. (2023) · Communications Biology · doi:10.1038/s42003-023-04902-2 · Cited by 41 · see citing works

Metabolic advantages of regulatory T cells dictated by cancer cells

Kondo, M., Kumagai, S., & Nishikawa, H. (2023) · International Immunology · doi:10.1093/intimm/dxad035 · Cited by 41 · see citing works

The Adaptive Complexity of Cancer

Derbal, Y. (2018) · BioMed Research International · doi:10.1155/2018/5837235 · Cited by 40 · see citing works

Multi-Omics Analysis of Brain Metastasis Outcomes Following Craniotomy

Su, J., Song, Q., Qasem, S. A., O’Neill, S. S., Lee, J., Furdui, C. M., Pasche, B., Metheny‐Barlow, L. J., Masters, A. H., Lo, H., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.615472 · Cited by 39 · see citing works

Metabolic regulation of the glioblastoma stem cell epitranscriptome by malate dehydrogenase 2

Lv, D., Dixit, D., Cruz, A. F., Kim, L. J. Y., Duan, L., Xu, X. Y., Wu, Q., Zhong, C., Lu, C., Gersey, Z. C., et al. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.09.014 · Cited by 38 · see citing works

The landscape of cancer-rewired GPCR signaling axes

Arora, C., Matic, M., Bisceglia, L., Chiaro, P. D., Rosa, N. D. O., Carli, F., Clubb, L. M., Fard, L. A. N., Kargas, G., Diaferia, G. R., et al. (2024) · Cell Genomics · doi:10.1016/j.xgen.2024.100557 · Cited by 36 · see citing works

The Metabolic Profile of Tumor and Virally Infected Cells Shapes Their Microenvironment Counteracting T Cell Immunity

Magalhaes, I., Yogev, O., Mattsson, J., & Schurich, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02309 · Cited by 34 · see citing works

Tissue metabolic profiling reveals major metabolic alteration in colorectal cancer

Shen, Y., Sun, M., Zhu, J. W., Wei, M., Li, H., Zhao, P., Wang, J., Li, R., Tian, L., Tao, Y., et al. (2021) · Molecular Omics · doi:10.1039/d1mo00022e · Cited by 33 · see citing works

Rapid Prostate Cancer Noninvasive Biomarker Screening Using Segmented Flow Mass Spectrometry-Based Untargeted Metabolomics

Pinto, F. G., Mahmud, I., Harmon, T. A., Rubio, V. Y., & Garrett, T. J. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00006 · Cited by 29 · see citing works

Risk stratification and pathway analysis based on graph neural network and interpretable algorithm

Liang, B., Gong, H., Lu, L., & Xu, J. (2022) · BMC Bioinformatics · doi:10.1186/s12859-022-04950-1 · Cited by 32 · see citing works

The molecular subtyping and precision medicine in triple-negative breast cancer---based on Fudan TNBC classification

Weng, L., Zhou, J., Guo, S., Xu, N., & Ma, R. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03261-0 · Cited by 30 · see citing works

Imaging Mass Spectrometry Reveals Crosstalk between the Fallopian Tube and the Ovary that Drives Primary Metastasis of Ovarian Cancer

Zink, K. E., Dean, M., Burdette, J. E., & Sanchez, L. M. (2018) · ACS Central Science · doi:10.1021/acscentsci.8b00405 · Cited by 30 · see citing works

Total Cellular ATP Production Changes With Primary Substrate in MCF7 Breast Cancer Cells

Louie, M. C., Ton, J., Brady, M. L., Le, D. T., Mar, J. N., Lerner, C. A., Gerencser, A. A., & Mookerjee, S. A. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01703 · Cited by 30 · see citing works

Immuno-Metabolism: The Role of Cancer Niche in Immune Checkpoint Inhibitor Resistance

Weng, C.-Y., Kao, C.-X., Chang, T., & Huang, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031258 · Cited by 29 · see citing works

Metabolism of cancer cells commonly responds to irradiation by a transient early mitochondrial shutdown

Krysztofiak, A., Szymonowicz, K., Hlouschek, J., Xiang, K., Waterkamp, C., Larafa, S., Goetting, I., Vega-Rubín-de-Celis, S., Theiß, C., Matschke, V., et al. (2021) · iScience · doi:10.1016/j.isci.2021.103366 · Cited by 29 · see citing works

Immune-Checkpoint Inhibitors Combinations in Metastatic NSCLC: New Options on the Horizon?

Passiglia, F., Reale, M. L., Cetoretta, V., & Novello, S. (2021) · ImmunoTargets and Therapy · doi:10.2147/itt.s253581 · Cited by 27 · see citing works

Targeted cancer treatment using a combination of siRNA-liposomes and resveratrol-electrospun fibers in co-cultures

Al-Attar, T., & Madihally, S. V. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118599 · Cited by 26 · see citing works

Characterizing the Metabolic and Immune Landscape of Non-small Cell Lung Cancer Reveals Prognostic Biomarkers Through Omics Data Integration

Wang, F., Zhang, Y., Hao, Y., Li, X., Qi, Y., Xin, M., Xiao, Q., & Wang, P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.702112 · Cited by 25 · see citing works

Artificial intelligence uncovers carcinogenic human metabolites

Mittal, A., Mohanty, S. K., Gautam, V., Arora, S., Saproo, S., Gupta, R., Sivakumar, R., Garg, P., Aggarwal, A., Raghavachary, P., et al. (2022) · Nature Chemical Biology · doi:10.1038/s41589-022-01110-7 · Cited by 24 · see citing works

Integrated spatial omics of metabolic reprogramming and the tumor microenvironment in pancreatic cancer

Wu, H., Zhang, Q., Cao, Z., Cao, H., Wu, M., Fu, M., Huang, T., Han, X., Chang, X., & Liu, Z. (2025) · iScience · doi:10.1016/j.isci.2025.112681 · Cited by 23 · see citing works

Amino acid metabolism regulated by lncRNAs: the propellant behind cancer metabolic reprogramming

Hu, Q., Li, Y., Li, D., Yuan, Y., Wang, K., Lü, Y., Cheng, Z., & Han, T. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01116-1 · Cited by 23 · see citing works

Immunometabolic coevolution defines unique microenvironmental niches in ccRCC

Tang, C., Xie, A., Liu, E. M., Kuo, F., Kim, M., DiNatale, R. G., Golkaram, M., Chen, Y., Gupta, S., Motzer, R. J., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.06.005 · Cited by 24 · see citing works

Transcending frontiers in prostate cancer: the role of oncometabolites on epigenetic regulation, CSCs, and tumor microenvironment to identify new therapeutic strategies

Ambrosini, G., Cordani, M., Zarrabi, A., Alcón-Rodríguez, S., Sainz, R. M., Velasco, G., González‐Menéndez, P., & Dando, I. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-023-01462-0 · Cited by 25 · see citing works

Quantification of IDO1 enzyme activity in normal and malignant tissues

Zhai, L., Ladomersky, E., Bell, A., Dussold, C., Cardoza, K., Qian, J., Lauing, K. L., & Wainwright, D. A. (2019) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2019.07.006 · Cited by 22 · see citing works

IDO, TDO, and AHR overexpression is associated with poor outcome in diffuse large B-cell lymphoma patients in the rituximab era

Chen, X., Zang, Y., Li, D., Guo, J., Wang, Y., Lin, Y., & Wei, Z. (2020) · Medicine · doi:10.1097/md.0000000000019883 · Cited by 22 · see citing works

Omics Notebook: robust, reproducible and flexible automated multiomics exploratory analysis and reporting

Blum, B. C., & Emili, A. (2021) · Bioinformatics Advances · doi:10.1093/bioadv/vbab024 · Cited by 21 · see citing works

Dietary approaches for exploiting metabolic vulnerabilities in cancer

Menyhárt, O., & Győrffy, B. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.189062 · Cited by 21 · see citing works

Anticancer Properties of Kaempferol on Cellular Signaling Pathways

Sengupta, B., Biswas, P., Roy, D., Lovett, J., Simington, L., Fry, D. R., & Travis, K. (2022) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026622666220907112822 · Cited by 20 · see citing works

Metabolomics informs common patterns of molecular dysfunction across histologies of renal cell carcinoma

DiNatale, R. G., Sánchez, A., Hakimi, A. A., & Reznik, E. (2019) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2019.04.028 · Cited by 20 · see citing works

Simvastatin inhibits PD-L1 via ILF3 to induce ferroptosis in gastric cancer cells

Sun, D., Cui, X., Yang, W., Meng, W., Yan, Z., Zhang, M., Yu, W., & Yu, W. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07562-8 · Cited by 19 · see citing works

The Future of Tumor Markers: Advancing Early Malignancy Detection Through Omics Technologies, Continuous Monitoring, and Personalized Reference Intervals

Savaş, İ. N., & Coşkun, A. (2025) · Biomolecules · doi:10.3390/biom15071011 · Cited by 22 · see citing works

Glucose makes Treg lose their temper

Villa, M., O’Sullivan, D., & Pearce, E. L. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.03.001 · Cited by 19 · see citing works

Targeting the spectrum of immune checkpoints in prostate cancer

Sena, L. A., Denmeade, S. R., & Antonarakis, E. S. (2021) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2021.1949287 · Cited by 19 · see citing works

Intrinsic STING of CD8 + T cells regulates self-metabolic reprogramming and memory to exert anti-tumor effects

Xu, Q., Hua, X., Li, B., Jiang, B., Jin, J., Wu, R., Gu, Y., Xu, H., Cheng, Q., Zhu, S., et al. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02069-3 · Cited by 18 · see citing works

Mitonuclear genotype remodels the metabolic and microenvironmental landscape of Hürthle cell carcinoma

Ganly, I., Liu, E. M., Kuo, F., Makarov, V., Dong, Y., Park, J., Gong, Y., Gorelick, A. N., Knauf, J. A., Benedetti, E., et al. (2022) · Science Advances · doi:10.1126/sciadv.abn9699 · Cited by 18 · see citing works

Aldose reductase and cancer metabolism: The master regulator in the limelight

Syamprasad, N. P., Jain, S., Rajdev, B., Prasad, N., Kallipalli, R., & Naidu, V. G. M. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115528 · Cited by 18 · see citing works

State of CD8+ T cells in progression from nonalcoholic steatohepatitis to hepatocellular carcinoma: From pathogenesis to immunotherapy.

Zhong, X., Lv, M.-L., Ma, M.-Q., Huang, Q., Hu, R., Li, J., Yi, J., Sun, J.-L., & Zhou, X.-Z. (2023) · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · doi:10.1016/j.biopha.2023.115131 · Cited by 20 · see citing works

Elucidating the Influence of MPT-driven necrosis-linked LncRNAs on immunotherapy outcomes, sensitivity to chemotherapy, and mechanisms of cell death in clear cell renal carcinoma

Huang, J., Liu, M., Chen, H., Zhang, J., Xie, X., Jiang, L., Zhang, S., Jiang, C., Zhang, J., Zhang, Q., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1276715 · Cited by 17 · see citing works

Metabolic heterogeneity in tumor microenvironment – A novel landmark for immunotherapy

Chen, C., Han, P., & Qing, Y. (2024) · Autoimmunity Reviews · doi:10.1016/j.autrev.2024.103579 · Cited by 17 · see citing works

Common biochemical properties of metabolic genes recurrently dysregulated in tumors

Oruganty, K., Campit, S., Mamde, S., Lyssiotis, C. A., & Chandrasekaran, S. (2020) · Cancer & Metabolism · doi:10.1186/s40170-020-0211-1 · Cited by 17 · see citing works

Blood Plasma Metabolome Profiling at Different Stages of Renal Cell Carcinoma

Maslov, D. L., Trifonova, O. P., Lichtenberg, S., Balashova, E. E., Mamedli, Z. Z., Alferov, A. A., Stilidi, I. S., Lokhov, P. G., Кушлинский, Н. Е., & Archakov, A. I. (2022) · Cancers · doi:10.3390/cancers15010140 · Cited by 16 · see citing works

Assessing the potential causal effects of 1099 plasma metabolites on 2099 binary disease endpoints

Yin, X., Li, J., Bose, D., Okamoto, J., Kwon, A., Jackson, A., Silva, L. F., Oravilahti, A., Chu, X., Stringham, H. M., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-58129-2 · Cited by 15 · see citing works

Exploring the Metabolic Heterogeneity of Cancers: A Benchmark Study of Context-Specific Models

Jalili, M., Scharm, M., Wolkenhauer, O., Damaghi, M., & Salehzadeh‐Yazdi, A. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11060496 · Cited by 15 · see citing works

Impact of Immunometabolism on Cancer Metastasis: A Focus on T Cells and MacrophagesPreprint

Flerin, N. C., Pinioti, S., Menga, A., Castegna, A., & Mazzone, M. (2019) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a037044 · Cited by 16 · see citing works

Machine learning facilitates the application of mass spectrometry-based metabolomics to clinical analysis: A review of early diagnosis of high mortality rate cancers

Ngan, H., Lam, K.-Y., Li, Z., Zhang, J., & Cai, Z. (2023) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2023.117333 · Cited by 15 · see citing works

Systematic alteration of in vitro metabolic environments reveals empirical growth relationships in cancer cell phenotypes

Kochanowski, K., Sander, T., Link, H., Chang, J. B., Altschuler, S. J., & Wu, L. F. (2021) · Cell Reports · doi:10.1016/j.celrep.2020.108647 · Cited by 15 · see citing works

STUB1-mediated ubiquitination regulates the stability of GLUD1 in lung adenocarcinoma

Hu, Q., Lei, J., Cheng, Z., Xu, J., Wang, L., Yuan, Y., Gan, M., Wang, Y., Xie, Y., Yao, L., et al. (2023) · iScience · doi:10.1016/j.isci.2023.107151 · Cited by 14 · see citing works

Urinary fatty acid biomarkers for prostate cancer detection

Landa, E. N., Quaye, G. E., Su, X., Badmos, S., Holbrook, K. L., Polascik, T. J., Adams, E. S., DEIVASIGAMANI, S. R., Gao, Q., Annabi, M. H., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0297615 · Cited by 12 · see citing works

MTHFD1 regulates the NADPH redox homeostasis in MYCN-amplified neuroblastoma

Guan, J., Li, M., Wang, Y., Zhang, Y., Que, Y., Lu, S., Wang, J., Zhu, J., Huang, J., Zhen, Z., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06490-3 · Cited by 12 · see citing works

Capturing Small Molecule Communication Between Tissues and Cells Using Imaging Mass Spectrometry

Zink, K. E., Dean, M., Burdette, J. E., & Sanchez, L. M. (2019) · Journal of Visualized Experiments · doi:10.3791/59490 · Cited by 12 · see citing works

Crosstalk between Metabolite Production and Signaling Activity in Breast Cancer

Çubuk, C., Loucera, C., Peña-Chilet, M., & Dopazo, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087450 · Cited by 11 · see citing works

Multiomic Metabolic Enrichment Network Analysis Reveals Metabolite–Protein Physical Interaction Subnetworks Altered in Cancer

Blum, B. C., Lin, W., Lawton, M. L., Liu, Q., Kwan, J., Turcinovic, I., Hekman, R. M., Hu, P., & Emili, A. (2021) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2021.100189 · Cited by 10 · see citing works

Multi-Modal Metabolomics Deciphers Pan-Cancer Metabolic Landscapes and Spatial-Niche-Specific Alternations

Feng, T., Piao, H., & Chen, D. (2026) · Metabolites · doi:10.3390/metabo16020129 · Cited by 1 · see citing works

Pan-cancer analysis of tumor metabolic landscape associated with genomic alterations

Choi, H., & Na, K. J. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0895-9 · Cited by 26 · see citing works

Pan-Cancer, Genome-Scale Metabolic Network Analysis of over 10,000 Patients Elucidates Relationship between Metabolism and Survival

Bucksot, J. E., Ritchie, K., Biancalana, M., Cole, J. A., & Cook, D. (2024) · Cancers · doi:10.3390/cancers16132302 · Cited by 4 · see citing works

Identifying Personalized Metabolic Signatures in Breast Cancer

Baloni, P., Dinalankara, W., Earls, J. C., Knijnenburg, T., Geman, D., Marchionni, L., & Price, N. D. (2020) · Metabolites · doi:10.3390/metabo11010020 · Cited by 15 · see citing works

Pan-cancer analysis of the metabolic reaction network

Gatto, F., Ferreira, R., & Nielsen, J. (2019) · Metabolic Engineering · doi:10.1016/j.ymben.2019.09.006 · Cited by 52 · see citing works